CORRELATION OF SIX-MINUTE WALK TEST AND COPD ASSESSMENT TEST (CAT) SCORES WITH SPIROMETRIC INDICES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL IN CHENNAI
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2017, Vol 6, Issue 70
Abstract
BACKGROUND Spirometric measurement of post-bronchodilator FEV1 is essential for establishing the diagnosis, assessment of severity, to predict the outcome and to assess response to treatment in COPD. Measurement of the walking distance is used to assess functional capacity of patients with COPD. Six-minute walk test (6MWT) is a simple, objective, and reproducible test. The facility of spirometry is not available in many rural areas of India because of lack of infrastructure where 6MWT can be done easily. The COPD assessment test (CAT) is a validated test for evaluation of COPD impact on health status. Therefore, in this study, we aim to find relationship between Six-minute walk test, Spirometry and COPD Assessment Test (CAT) scores in chronic obstructive pulmonary disease patients. MATERIALS AND METHODS Seventy-five patients of COPD were enrolled for the study after applying inclusion and exclusion criteria. The impact of COPD on health status was assessed using CAT score. All patients underwent spirometric measurement of FEV1, FVC, and ratio of FEV1 and FVC and test repeated after bronchodilation by 200–400 μg of salbutamol. 6MWT was performed following American Thoracic Society (ATS) protocol of 6MWT and distance was measured in metres. The results were analysed using SPSS software version 19. RESULTS We found significant linear correlation of 6MWD with post-FEV1(r=0.561, P<0.001), post-FVC (r=0.341, P=0.003), and FEV1/FVC (r = 0.476, P < 0.001). The mean CAT score was 20.49 ± 5.34 SD. There was a significant association between post-FEV1 and total CAT score (P< 0.001). The correlation between mean post-FEV1 and mean score of CAT groups 1,2, 3, and 4 was statistically significant (P<0.001). CONCLUSION 6MWT can be a useful replacement of spirometry in assessment of severity of COPD. The relationship between CAT score and postFEV1 suggests that CAT is linked to severity of airflow limitation and GOLD classification in stable COPD patients. Spirometry is not needed every time to assess the severity of COPD. However, Spirometry is necessary to diagnose COPD. CAT score can be used to assess the impact of COPD on health status and quality of life. Both 6MWT and CAT score can be used even in a rural setting where most of the COPD patients have no access to spirometry.
Authors and Affiliations
Vengada Krishnaraj S. P, Anand Pugazhendhi, Vinod Kumar Viswanathan, Sridhar Rathinam
Keywords
Related Articles
- EP ID EP233445
- DOI 10.14260/Jemds/2017/1082
- Views 57
- Downloads 0
PERI-OPERATIVE SYNTOCINON INFUSION IN LSCS
BACKGROUND Oxytocin for the purposes of augmentation and induction of labour is one of the most frequently used medications in obstetrics. Recent studies show that oxytocin is used in over 50% of labouring women in some...
A PROSPECTIVE RANDOMISED CONTROL STUDY TO ASSESS THE EFFICACY OF INTRAOPERATIVE DEXMED INFUSION ON EMERGENCE AGITATION AND QUALITY OF RECOVERY IN NASAL SURGERY
BACKGROUND Emergence agitation is usually common after nasal surgery. We underwent investigation to find the effects of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal s...
THE STUDY OF CHANGES IN SERUM ELECTROLYTES (Na+, K+, Ca++, Mg++) IN ALUMINIUM PHOSPHIDE POISONING PATIENTS- IS THERE ANY CORRELATION WITH MORTALITY OR SURVIVAL
BACKGROUND Aluminium phosphide (ALP), a solid fumigant pesticide was declared as an ideal fumigant pesticide in 1973 because of its effectiveness, low cost and ease to use. Its toxic effects on humans are due to liberati...
MUCOCUTANEOUS ADVERSE EFFECTS IN PATIENTS UNDERGOING CANCER CHEMOTHERAPY
BACKGROUND New chemotherapeutic agents and new protocols in oncology have led to an increasing survival rate in patients affected by tumours. Traditional chemotherapy drugs as well as the newer targeted agents are associ...
PREVALENCE AND SEVERITY OF ANAEMIA AMONG HOSPITALISED CHILDREN AGED 6-59 MONTHS
BACKGROUND Anaemia is ubiquitous and has a global prevalence, more so in developing countries. Globally, anaemia affects 1.62 billion people, which corresponds to 24.8% of the population and the highest prevalence is not...